Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
_
_  
Search: 
 
_
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Severe Acute Respiratory Syndrome (SARS)
SARS Update—May 19, 2004
May 19, 2004

May 19, 2004 Update

During April 22-29, the Chinese Ministry of Health (MOH) reported a total of nine cases of SARS in China ; seven of the patients were from Beijing , and two were from Anhui Province , located in east-central China . One of the patients died.

Two of the nine patients were graduate students who worked at the China ’s National Institute of Virology Laboratory (NIVL) in Beijing , which is known to conduct research on SARS coronavirus (SARS-CoV). The laboratory was closed on April 23, potentially exposed personnel are being monitored for signs of illness, and possible sources of infection for the two laboratory workers are being investigated.

Of the seven other SARS cases, two were directly linked to close personal contact with one of the graduate students who worked at NIVL; these two cases were in the graduate student’s mother (who died) and in a nurse who provided care to the graduate student. The remaining five cases were linked to close contact with the nurse.

No further cases of SARS in China or anywhere else in the world have been reported since April 29. Chinese authorities have carried out active surveillance activities to identify other possible cases of SARS, including enhanced surveillance for any flu-like illness and pneumonia of unknown etiology. They also initiated measures to prevent the spread of SARS among travelers, including health screening of travelers at ports of exit/entry.

On May 18, the World Health Organization (WHO) reported on its website that the outbreak in China appears to have been contained, but that biosafety concerns remain and further investigation is under way. WHO and Chinese health officials are still in the process of determining precisely what caused the outbreak.

CDC is in close communication with WHO and is working with its public health partners to reinforce the need for strict adherence to applicable biosafety precautions to reduce the risk of laboratory-related exposures to SARS-CoV.

For More Information:

Archived News

Updated information on SARS is provided on CDC's SARS website.

Travel information is provided on CDC's Travelers' Health website.


_
_
Topic Contents
_ arrow SARS Home
  arrow Community Containment
  arrow Evaluation/Diagnosis
  arrow Exposure Management
  arrow Infection Control
  arrow Laboratory
  arrow Legal Authorities
  arrow Preparedness Planning
  arrow References & Resources
  arrow Surveillance & Reporting
  arrow Travel
  arrow What Everyone Should Know
  arrow What's New
_
_
blackdots
_

Contact Info

Public:
English 888-246-2675
Español 888-246-2857
TTY 866-874-2646
Clinician:
English 877-554-4625
_
arrow Sign up for the Clinician Registry
arrow Contact Us
_
blackdots
_
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People FirstGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435